Center Publications

Samuel, Varman T, and Gerald I Shulman. “Nonalcoholic Fatty Liver Disease As a Nexus of Metabolic and Hepatic Diseases”. 2018. Cell Metabolism, vol. 27, no. 1, 2018, pp. 22–41.

Williams, Bianca, et al. “A Novel Role for Ceramide Synthase 6 in Mouse and Human Alcoholic Steatosis”. 2018. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 32, no. 1, 2018, pp. 130–142.

Kushwaha, Priyanka, et al. “Fatty Acid Metabolism by the Osteoblast”. 2018. Bone, vol. 115, 2018, pp. 8–14.

François, Marie, et al. “Genetics-Based Manipulation of Adipose Tissue Sympathetic Innervation”. 2018. Physiology & Behavior, vol. 190, 2018, pp. 21–27.

Han, Seung Jin, et al. “Change in Visceral Adiposity Is an Independent Predictor of Future Arterial Pulse Pressure”. 2018. Journal of Hypertension, vol. 36, no. 2, 2018, pp. 299–305.

Akinyemiju, Tomi, et al. “In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients With Metabolic Syndrome”. 2018. Obesity Surgery, vol. 28, no. 3, 2018, pp. 683–692.

Friedman, Scott L, et al. “A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis With Fibrosis”. 2018. Hepatology (Baltimore, Md.), vol. 67, no. 5, 2018, pp. 1754–1767.

Breyer, Benjamin N, et al. “A Behavioral Weight Loss Program and Nonurinary Incontinence Lower Urinary Tract Symptoms in Overweight and Obese Women With Urinary Incontinence: A Secondary Data Analysis of PRIDE”. 2018. The Journal of Urology, vol. 199, no. 1, 2018, pp. 215–222.

Lynes, Matthew D, and Yu-Hua Tseng. “Deciphering Adipose Tissue Heterogeneity”. 2018. Annals of the New York Academy of Sciences, vol. 1411, no. 1, 2018, pp. 5–20.

Koletzko, Sibylle, et al. “Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy Study”. 2018. Journal of Pediatric Gastroenterology and Nutrition, vol. 66, no. 3, 2018, pp. 417–424.

Chemaly, Elie R, et al. “SERCA Control of Cell Death and Survival”. 2018. Cell Calcium, vol. 69, 2018, pp. 46–61.

Rotroff, Daniel M, et al. “Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes”. 2018. Clinical Pharmacology and Therapeutics, vol. 103, no. 4, 2018, pp. 712–721.